Frankenius Equity AB 13D and 13G filings for TriSalus Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-19 4:12 pm Purchase |
2024-12-17 | 13D | TriSalus Life Sciences, Inc. TLSI |
Frankenius Equity AB | 6,488,719 20.900% |
90,943 (+1.42%) |
Filing |
| 2023-08-21 4:33 pm Purchase |
2023-08-10 | 13D | TriSalus Life Sciences, Inc. TLSI |
Frankenius Equity AB | 6,397,776 24.100% |
6,397,776 (New Position) |
Filing |